Currently holds a position at Mirati Therapeutics Inc
Position | Company | Period |
---|---|---|
Executive Vice President, Chief Scientific Officer | Mirati Therapeutics Inc | Dec. 1, 2018 - |
Senior Vice President, Chief Scientific Officer | Mirati Therapeutics Inc | Jan. 22, 2014 - Jan. 1, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-01-05 | 2023-01-04 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
1,949
-1.9%
46.6090,823 USD |
1,949 -1.9% | 46.60 | 90,823 USD | |
2022-12-20 | 2022-12-16 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
2,410
-2.3%
43.00103,624 USD |
2,410 -2.3% | 43.00 | 103,624 USD | |
2022-12-05 | 2022-12-02 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
1,726
-1.6%
90.19155,667 USD |
1,726 -1.6% | 90.19 | 155,667 USD | |
2022-01-18 | 2022-01-18 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
627
-0.7%
120.5175,558 USD |
627 -0.7% | 120.51 | 75,558 USD | |
2022-01-06 | 2022-01-04 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
1,442
-1.8%
147.72213,017 USD |
1,442 -1.8% | 147.72 | 213,017 USD | |
2021-12-07 | 2021-12-06 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
9
-0.0%
132.001,188 USD |
9 -0.0% | 132.00 | 1,188 USD | |
2021-12-07 | 2021-12-06 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
1,192
-2.0%
130.78155,890 USD |
1,192 -2.0% | 130.78 | 155,890 USD | |
2021-05-25 | 2021-05-24 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
435
-0.8%
154.3467,138 USD |
435 -0.8% | 154.34 | 67,138 USD | |
2021-01-08 | 2021-01-06 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
1,430
-2.9%
210.28300,700 USD |
1,430 -2.9% | 210.28 | 300,700 USD | |
2021-01-08 | 2021-01-06 |
Mirati Therapeutics Inc
(MRTX)
|
S Sale |
29
-0.1%
215.876,260 USD |
29 -0.1% | 215.87 | 6,260 USD |